Early research (Phase 1)Looking for participantsNCT05772455What this trial is testingXZB-0004 in Patients With Solid TumorsWho this might be right forAdvanced Solid TumorNSCLC Xuanzhu Biopharmaceutical Co., Ltd. 128
Testing effectiveness (Phase 2)Study completedNCT03213678What this trial is testingSamotolisib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial)Who this might be right forAdvanced Malignant Solid NeoplasmAnn Arbor Stage III Non-Hodgkin LymphomaAnn Arbor Stage IV Non-Hodgkin Lymphoma+30 more National Cancer Institute (NCI) 18
Testing effectiveness (Phase 2)Study completedNCT01606748What this trial is testingA Drug-Interaction Study of Necitumumab (IMC-11F8) in Combination With Gemcitabine-CisplatinWho this might be right forMalignant Solid Tumor Eli Lilly and Company 35
Early research (Phase 1)UnknownNCT05836623What this trial is testingA Phase I Study to Assess PSMA+ and PSMA- Tumour LesionsWho this might be right forAdvanced and/or Metastatic Solid Tumours Crescendo Biologics Ltd. 5
Early research (Phase 1)Study completedNCT03218826What this trial is testingPI3Kbeta Inhibitor AZD8186 and Docetaxel in Treating Patients Advanced Solid Tumors With PTEN or PIK3CB Mutations That Are Metastatic or Cannot Be Removed by SurgeryWho this might be right forAdvanced Breast CarcinomaAdvanced Malignant Solid NeoplasmAdvanced Prostate Carcinoma+23 more National Cancer Institute (NCI) 23
Testing effectiveness (Phase 2)Looking for participantsNCT06961006What this trial is testingA Clinical Study of Intismeran Autogene (V940) and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-012)Who this might be right forMalignant Melanoma Merck Sharp & Dohme LLC 160
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07631884What this trial is testingExploratory Study on the Efficacy and Safety of Trastuzumab Rezetecan in the Treatment of HER2-Expressiong Advanced Solid TumorWho this might be right forSolid TumorsNeoplasms (Cancer / Tumors)Advanced Malignant Solid Neoplasm+13 more Haihua Yuan 15
Testing effectiveness (Phase 2)Study completedNCT00264004What this trial is testingStudy to Investigate the Management of Hypertension and Efficacy of AZD2171 in Patients With Advanced Solid TumoursWho this might be right forTumors AstraZeneca 119
Not applicableEnded earlyNCT05477784What this trial is testingCancer Parenting Program for the Enhancement of the Quality of Life of Patients With Advanced Cancer and Their ChildrenWho this might be right forParent-Child RelationsCancerSurvivorship+4 more University of Washington 174
Testing effectiveness (Phase 2)Study completedNCT01827384What this trial is testingMPACT Study to Compare Effects of Targeted Drugs on Tumor Gene VariationsWho this might be right forAdvanced Malignant Solid Neoplasm National Cancer Institute (NCI) 208
Testing effectiveness (Phase 2)Looking for participantsNCT06888830What this trial is testingA Phase I/II Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Initial Efficacy of JS212 in Subjects With Advanced Malignant Solid TumourWho this might be right forAdvanced Malignant Solid Tumours Shanghai Junshi Bioscience Co., Ltd. 374
Testing effectiveness (Phase 2)Study completedNCT01653028What this trial is testingAlisertib in Treating Patients With Advanced or Metastatic SarcomaWho this might be right forMyxofibrosarcomaRecurrent Adult Soft Tissue SarcomaRecurrent Leiomyosarcoma+5 more National Cancer Institute (NCI) 72
Large-scale testing (Phase 3)Ended earlyNCT02967692What this trial is testingThe Anti-PD1 Antibody PDR001, in Combination With Dabrafenib and Trametinib in Advanced MelanomaWho this might be right forMelanoma Novartis Pharmaceuticals 568
Large-scale testing (Phase 3)Study completedNCT04889118What this trial is testingSafety and Efficacy Study of Pembrolizumab (MK-3475) Combined With Lenvatinib (MK-7902/E7080) as First-line Intervention in Adults With Advanced Melanoma (MK-7902-003/E7080-G000-312/LEAP-003)-China Extension StudyWho this might be right forMalignant Melanoma Merck Sharp & Dohme LLC 131
Early research (Phase 1)Looking for participantsNCT06911008What this trial is testingMTI-301 for the Treatment of Metastatic or Unresectable and Refractory Solid CancersWho this might be right forMetastatic Malignant Solid NeoplasmRefractory Malignant Solid NeoplasmUnresectable Malignant Solid Neoplasm Mayo Clinic 42
Testing effectiveness (Phase 2)UnknownNCT02005120What this trial is testingIntrapleural Administration of Bevacizumab Versus Endostar for Pleural Effusions in NSCLCWho this might be right forNon Small Cell Lung Cancer Zhejiang University 20
Early research (Phase 1)Study completedNCT00161642What this trial is testingStudy Evaluating CMD-193 in Advanced Malignant Solid TumorsWho this might be right forNeoplasms Wyeth is now a wholly owned subsidiary of Pfizer 54
Early research (Phase 1)Study completedNCT01207323What this trial is testingThe Safety and Pharmacokinetics (PK) of MEHD7945A in Participants With Locally Advanced or Metastatic Epithelial TumorsWho this might be right forEpithelial Tumors, Malignant Genentech, Inc. 66
Testing effectiveness (Phase 2)Looking for participantsNCT04299191What this trial is testingStudy of LAM561 Acid in Pediatric Patients With Malignant Glioma and Other Advanced Solid TumorsWho this might be right forHigh-grade GliomaSolid Tumor, Unspecified, Child Laminar Pharmaceuticals 28
Not applicableLooking for participantsNCT07174661What this trial is testingEducational Tools for the Improvement of Early Advance Care Planning in Adolescents and Young Adults With Advanced Solid Tumors and High-Grade Brain TumorsWho this might be right forAdvanced Malignant Solid NeoplasmMalignant Brain NeoplasmRecurrent Advanced Malignant Solid Neoplasm Mayo Clinic 50